A multicenter phase II study of belotecan, a new camptothecin analogue, as a second-line therapy in patients with small cell lung cancer
Rhee, Chin Kook, Lee, Sang Haak, Kim, Ju Sang, Kim, Seung Joon, Kim, Seok Chan, Kim, Young Kyoon, Kang, Hyun Hee, Yoon, Hyoung Kyu, Song, Jeong Sup, Moon, Hwa Sik, Kim, Jin Woo, Kim, Chi Hong, Shim, BVolume:
72
Langue:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2010.07.003
Date:
April, 2011
Fichier:
PDF, 169 KB
english, 2011